The weight-loss medication, Semaglutide, described as a ‘game-changer’ by obesity researchers was recently approved by the US Food and Drug Administration (FDA), representing the first time the agency has endorsed such a medication for the treatment of Obesity in almost 10 years.
Semaglutide and other GLP– 1 Antagonist medications have been used for many years as medication for people with type-2 diabetes. Recently, research has shown there were more benefits beyond treating elevated blood sugars. These benefits include drastic weight loss, appetite suppression, loss of cravings and hunger and more.
Study findings demonstrated truly remarkable results. Over 70% of participants lost anywhere from 15-20% of their total body weight. This is over double weight loss than any other FDA approved weight loss medication on the market today.
● Feel full faster
● Slower digestion through stomach
● Better Sleep Patterns
● Lowers Leptin Levels
● Lowers Blood Sugars
● Diminish Hunger and Cravings
● Lowers A1c levels
● Appetite Suppression
Tirzepatide has been shown to help lose weight in overweight patients. Phase 3 clinical trials are currently underway for weight loss in adults who are overweight, obese, or have weight-related health issues. Tirzepatide has received FDA Fast Track designation to speed up its FDA application for treating adults with obesity, or who are overweight with weight-related health conditions.
Benefits: Increased energy & metabolism, increased fat burning, better sleep & mood, liver detox.
30 day prescription only medication (Naltrexone/Phentermine/B12). Medical provider consultation & inBody composition analysis. Benefits: increase metabolism, decrease hunger, stop cravings, & boost energy levels.
Consultation with a certified nutritionist including meal planning & 30 days of follow up virtual appointment to help with accountability.